by Benjamin H. Rudolph and Viqar Aslam, Aptagen, Inc. One company shows the world that stem cell research isn't coing away -- and receives a worldwide ctroversy in the process.
Viqar Aslam
Advertisement
Articles by Viqar Aslam
Advertisement
Latest Updated Articles
- Your Vested Interests: The War of the West
January 15th 2002
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
2
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
3
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
4
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
5